Dr. Knudson is founder, President and Chief Executive Officer and Chairman of the Board of EnteroMedics Inc., which was established in late 2002 to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Prior to this, he served as the President at Johnson and Johnson Professional Diagnostics, following Johnson and Johnson's 1986 acquisition of Arden Medical Systems. He founded Arden in 1983 and was its Chairman, President, and Chief Executive Officer.
Dr. Knudson has also held positions in Research and Development Management at Cardiac Pacemakers, Inc., (CPI-Guidant) and as a partner of an early stage venture capital firm. His inventions have been the basis for the founding of nine companies, in several of which he served as founding Chief Executive Officer. Prior to their successful acquisition, Dr. Knudson founded and served on the Board of Directors of Arden Medical Systems, Inc., Integ, Inc., HeartStream, Inc., InControl, Inc, and was a Member of the Advisory Board at Artesian Capital. He was a member of the faculty of the University of Washington School of Medicine and is also a Fellow of the American Heart Association.
Dr. Knudson was the recipient of an Individual Post-doctoral Fellowship Award from the National Institutes of Health. Dr.Knudson is the holder of over 40 United States patents. He holds a Ph.D. in Cardiovascular Physiology from Washington State University and a B.S. degree in Biology from Pacific Lutheran University.